Jane Street Group LLC Sells 30,901 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Jane Street Group LLC lessened its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 47.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,472 shares of the company's stock after selling 30,901 shares during the quarter. Jane Street Group LLC owned 0.07% of Prestige Consumer Healthcare worth $2,692,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Kestra Investment Management LLC purchased a new position in Prestige Consumer Healthcare in the fourth quarter valued at approximately $27,000. CIBC Private Wealth Group LLC boosted its holdings in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after purchasing an additional 152 shares during the period. Headlands Technologies LLC bought a new position in Prestige Consumer Healthcare in the 4th quarter worth about $40,000. Johnson Financial Group Inc. purchased a new stake in Prestige Consumer Healthcare in the fourth quarter valued at approximately $93,000. Finally, Huntington National Bank grew its position in Prestige Consumer Healthcare by 133.2% in the fourth quarter. Huntington National Bank now owns 1,481 shares of the company's stock worth $116,000 after acquiring an additional 846 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Canaccord Genuity Group lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday. Royal Bank of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. DA Davidson boosted their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Finally, Oppenheimer lifted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday, February 13th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, Prestige Consumer Healthcare has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Performance

Shares of Prestige Consumer Healthcare stock traded down $0.04 during trading hours on Tuesday, reaching $88.90. 35,353 shares of the stock traded hands, compared to its average volume of 293,954. The company has a 50 day moving average price of $83.37 and a 200 day moving average price of $82.04. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $4.39 billion, a price-to-earnings ratio of 20.79, a P/E/G ratio of 2.69 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The business had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. During the same quarter in the previous year, the company posted $1.02 earnings per share. Prestige Consumer Healthcare's revenue for the quarter was up 7.0% on a year-over-year basis. On average, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now owns 17,157 shares in the company, valued at $1,544,130. This trade represents a 8.91% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 1.60% of the company's stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.